Share Price and Basic Stock Data
Last Updated: December 13, 2025, 9:15 am
| PEG Ratio | 4.29 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
UTI Asset Management Company Ltd (UTI AMC) operates in the financial sector, primarily focusing on mutual funds. The company reported a market capitalization of ₹14,400 Cr, with a current share price of ₹1,122. Its revenue from operations for the trailing twelve months (TTM) stood at ₹1,879 Cr, reflecting a robust growth trajectory compared to previous periods. For instance, revenue rose from ₹1,267 Cr in FY 2023 to ₹1,851 Cr in FY 2025, indicating a strong recovery post-pandemic. Notably, the quarterly sales trend shows a promising upward momentum, with sales touching ₹529 Cr in June 2024, compared to ₹293 Cr in June 2022. This growth in sales has been complemented by a stable operating profit margin (OPM) of around 60%, which is impressive for the asset management industry where margins can be volatile. Overall, UTI AMC appears well-positioned to capitalize on the growing mutual fund market in India, driven by increasing retail participation.
Profitability and Efficiency Metrics
When it comes to profitability, UTI AMC has demonstrated commendable performance. The net profit for the TTM was ₹793 Cr, with a net profit margin of approximately 43.91% in FY 2025. This figure is considerably higher than many peers in the sector, indicating effective cost management and operational efficiency. The company’s return on equity (ROE) was recorded at 16.3%, which, while slightly below some industry leaders, reflects a solid ability to generate returns for shareholders. Moreover, the interest coverage ratio (ICR) stood at a remarkable 87.37x, suggesting that the company comfortably covers its interest obligations, a crucial aspect for any financial entity. However, the fluctuating operating profit margin—from 64% in June 2023 to 45% in March 2025—raises some eyebrows. This could indicate potential pressures on profitability moving forward, especially if the company fails to maintain its competitive edge in a rapidly evolving market.
Balance Sheet Strength and Financial Ratios
UTI AMC’s balance sheet reflects a strong financial position, with no borrowings reported, which is a significant advantage in the finance sector. The reserves of ₹4,257 Cr as of September 2025 provide a solid buffer for future investments and operational stability. The price-to-book value (P/BV) ratio of 2.93x suggests that the stock is trading at a premium compared to its book value, which may indicate investor confidence in its growth prospects. Furthermore, the company has maintained a healthy current ratio of 15.50x, indicating strong liquidity and the ability to meet short-term obligations. However, the decline in the return on capital employed (ROCE) to 21% in FY 2025 from previous years could raise concerns about the efficiency of capital utilization. Investors will want to monitor these ratios closely, as they can provide insights into the company’s operational effectiveness and its ability to generate returns from its assets.
Shareholding Pattern and Investor Confidence
The shareholding pattern of UTI AMC reflects a stable and confident investor base, with domestic institutional investors (DIIs) holding 59.71% of the shares as of March 2025. This indicates strong institutional support, which is often a positive signal for retail investors. Foreign institutional investors (FIIs) hold a smaller portion at 7.62%, suggesting that while there is some interest from overseas, the bulk of the ownership lies with domestic players. The total number of shareholders has seen fluctuations, standing at 1,61,911 in September 2025. The consistent presence of DIIs can be interpreted as a vote of confidence in UTI AMC’s management and future prospects. Nevertheless, the slight decline in public shareholding could indicate a shift in retail investor sentiment, which might warrant further scrutiny in the future.
Outlook, Risks, and Final Insight
Looking ahead, UTI AMC faces both opportunities and challenges. The growing mutual fund market in India, driven by increasing financial literacy and retail participation, presents a significant opportunity for growth. However, the company must navigate potential risks such as regulatory changes and market volatility, which can impact asset management fees and investor sentiment. Additionally, the fluctuating operating profit margins could signal underlying challenges that may affect profitability. Investors might consider the strong institutional backing and solid balance sheet as strengths. Yet, the potential for margin compression and the company’s ability to maintain its competitive edge in a crowded market should weigh on their minds. In summary, while UTI AMC seems well-positioned for growth, careful consideration of these risks will be essential for any investor contemplating a stake in the company.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life AMC Ltd | 21,709 Cr. | 752 | 912/556 | 22.4 | 123 | 3.19 % | 35.5 % | 27.0 % | 5.00 |
| UTI Asset Management Company Ltd | 14,714 Cr. | 1,146 | 1,495/905 | 25.0 | 342 | 2.27 % | 21.0 % | 16.3 % | 10.0 |
| Nippon Life India Asset Management Ltd | 55,450 Cr. | 870 | 987/456 | 41.5 | 68.8 | 2.07 % | 40.7 % | 31.4 % | 10.0 |
| HDFC Asset Management Company Ltd | 1,14,560 Cr. | 2,675 | 2,967/1,763 | 41.7 | 181 | 1.68 % | 43.3 % | 32.4 % | 5.00 |
| Industry Average | 51,608.25 Cr | 1,360.75 | 32.65 | 178.70 | 2.30% | 35.13% | 26.78% | 7.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 293 | 435 | 295 | 301 | 468 | 404 | 449 | 416 | 529 | 538 | 418 | 376 | 547 |
| Expenses | 191 | 165 | 178 | 179 | 168 | 173 | 176 | 188 | 178 | 190 | 185 | 207 | 207 |
| Operating Profit | 103 | 270 | 117 | 122 | 300 | 232 | 273 | 228 | 351 | 348 | 233 | 169 | 340 |
| OPM % | 35% | 62% | 40% | 41% | 64% | 57% | 61% | 55% | 66% | 65% | 56% | 45% | 62% |
| Other Income | 13 | 4 | -2 | 8 | 1 | 2 | 1 | 4 | 5 | 2 | 3 | 0 | 2 |
| Interest | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 12 | 11 | 11 | 11 | 12 | 12 |
| Profit before tax | 104 | 262 | 103 | 117 | 288 | 220 | 261 | 218 | 341 | 336 | 221 | 154 | 326 |
| Tax % | 12% | 23% | 41% | 27% | 19% | 17% | 22% | 17% | 20% | 22% | 22% | 34% | 22% |
| Net Profit | 92 | 202 | 60 | 86 | 234 | 183 | 203 | 181 | 274 | 263 | 174 | 102 | 254 |
| EPS in Rs | 7.21 | 15.73 | 4.76 | 6.75 | 18.46 | 14.39 | 14.59 | 12.79 | 19.97 | 18.76 | 11.78 | 6.83 | 18.50 |
Last Updated: August 1, 2025, 9:40 am
Below is a detailed analysis of the quarterly data for UTI Asset Management Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 547.00 Cr.. The value appears strong and on an upward trend. It has increased from 376.00 Cr. (Mar 2025) to 547.00 Cr., marking an increase of 171.00 Cr..
- For Expenses, as of Jun 2025, the value is 207.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 207.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 340.00 Cr.. The value appears strong and on an upward trend. It has increased from 169.00 Cr. (Mar 2025) to 340.00 Cr., marking an increase of 171.00 Cr..
- For OPM %, as of Jun 2025, the value is 62.00%. The value appears strong and on an upward trend. It has increased from 45.00% (Mar 2025) to 62.00%, marking an increase of 17.00%.
- For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 326.00 Cr.. The value appears strong and on an upward trend. It has increased from 154.00 Cr. (Mar 2025) to 326.00 Cr., marking an increase of 172.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 34.00% (Mar 2025) to 22.00%, marking a decrease of 12.00%.
- For Net Profit, as of Jun 2025, the value is 254.00 Cr.. The value appears strong and on an upward trend. It has increased from 102.00 Cr. (Mar 2025) to 254.00 Cr., marking an increase of 152.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 18.50. The value appears strong and on an upward trend. It has increased from 6.83 (Mar 2025) to 18.50, marking an increase of 11.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:12 am
| Metric | Mar 2008 | Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 442 | 497 | 502 | 934 | 1,134 | 1,051 | 854 | 1,169 | 1,319 | 1,267 | 1,737 | 1,851 | 1,879 |
| Expenses | 219 | 292 | 298 | 499 | 577 | 552 | 506 | 526 | 621 | 655 | 703 | 749 | 789 |
| Operating Profit | 223 | 206 | 204 | 435 | 558 | 498 | 349 | 643 | 698 | 612 | 1,034 | 1,102 | 1,090 |
| OPM % | 50% | 41% | 41% | 47% | 49% | 47% | 41% | 55% | 53% | 48% | 60% | 60% | 58% |
| Other Income | 4 | 2 | 1 | 13 | 22 | 30 | 36 | 4 | 8 | 23 | 6 | 9 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 8 | 9 | 8 | 9 | 10 | 11 | 13 | 13 |
| Depreciation | 6 | 9 | 10 | 13 | 14 | 29 | 34 | 36 | 37 | 40 | 42 | 46 | 47 |
| Profit before tax | 221 | 199 | 195 | 435 | 566 | 491 | 341 | 603 | 660 | 586 | 987 | 1,052 | 1,037 |
| Tax % | 32% | 30% | 25% | 26% | 29% | 29% | 19% | 18% | 19% | 25% | 19% | 23% | |
| Net Profit | 151 | 139 | 147 | 321 | 402 | 348 | 275 | 494 | 535 | 440 | 802 | 813 | 793 |
| EPS in Rs | 12.12 | 11.12 | 11.73 | 25.29 | 31.68 | 27.83 | 21.41 | 38.97 | 42.09 | 34.44 | 60.17 | 57.16 | 55.87 |
| Dividend Payout % | 26% | 25% | 23% | 16% | 16% | 18% | 33% | 44% | 50% | 64% | 78% | 84% |
YoY Net Profit Growth
| Year | 2011-2012 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 5.76% | 25.23% | -13.43% | -20.98% | 79.64% | 8.30% | -17.76% | 82.27% | 1.37% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.48% | -38.67% | -7.54% | 100.61% | -71.34% | -26.06% | 100.03% | -80.90% |
UTI Asset Management Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2011-2012 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 12% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 11% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 17% |
| 1 Year: | 6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 16% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 10, 2025, 3:36 am
| Month | Mar 2008 | Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 125 | 125 | 125 | 127 | 127 | 127 | 127 | 127 | 127 | 127 | 127 | 128 | 128 |
| Reserves | 445 | 743 | 855 | 1,789 | 2,161 | 2,478 | 2,646 | 3,125 | 3,493 | 3,741 | 4,261 | 4,471 | 4,257 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 209 | 218 | 202 | 205 | 262 | 409 | 393 | 398 | 363 | 307 | 953 | 1,059 | 1,050 |
| Total Liabilities | 779 | 1,086 | 1,182 | 2,121 | 2,550 | 3,013 | 3,165 | 3,650 | 3,983 | 4,175 | 5,341 | 5,658 | 5,435 |
| Fixed Assets | 164 | 208 | 201 | 278 | 273 | 351 | 373 | 360 | 357 | 368 | 412 | 408 | 408 |
| CWIP | 0 | 0 | 0 | 3 | 5 | 1 | 1 | 5 | 8 | 9 | 3 | 11 | 2 |
| Investments | 391 | 646 | 720 | 1,543 | 1,932 | 2,261 | 2,356 | 2,747 | 2,994 | 3,248 | 4,428 | 4,558 | 4,414 |
| Other Assets | 223 | 232 | 260 | 297 | 339 | 400 | 436 | 539 | 623 | 550 | 498 | 681 | 612 |
| Total Assets | 779 | 1,086 | 1,182 | 2,121 | 2,550 | 3,013 | 3,165 | 3,650 | 3,983 | 4,175 | 5,341 | 5,658 | 5,435 |
Below is a detailed analysis of the balance sheet data for UTI Asset Management Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 128.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 128.00 Cr..
- For Reserves, as of Sep 2025, the value is 4,257.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,471.00 Cr. (Mar 2025) to 4,257.00 Cr., marking a decrease of 214.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,050.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,059.00 Cr. (Mar 2025) to 1,050.00 Cr., marking a decrease of 9.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,435.00 Cr.. The value appears to be improving (decreasing). It has decreased from 5,658.00 Cr. (Mar 2025) to 5,435.00 Cr., marking a decrease of 223.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 408.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 408.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 4,414.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,558.00 Cr. (Mar 2025) to 4,414.00 Cr., marking a decrease of 144.00 Cr..
- For Other Assets, as of Sep 2025, the value is 612.00 Cr.. The value appears to be declining and may need further review. It has decreased from 681.00 Cr. (Mar 2025) to 612.00 Cr., marking a decrease of 69.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,435.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,658.00 Cr. (Mar 2025) to 5,435.00 Cr., marking a decrease of 223.00 Cr..
Notably, the Reserves (4,257.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2008 | Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 223.00 | 206.00 | 204.00 | 435.00 | 558.00 | 498.00 | 349.00 | 643.00 | 698.00 | 612.00 | 1.00 | 1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2008 | Mar 2011 | Mar 2012 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 7 | 5 | 18 | 3 | 9 | 10 | 19 | 14 | 22 | 27 | 18 | 16 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 7 | 5 | 18 | 3 | 9 | 10 | 19 | 14 | 22 | 27 | 18 | 16 |
| Working Capital Days | -26 | -62 | -44 | -28 | -40 | -31 | -24 | -47 | -31 | -32 | -33 | -51 |
| ROCE % | 42% | 21% | 27% | 20% | 13% | 20% | 19% | 16% | 23% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Small Cap Fund | 2,250,684 | 0.73 | 280.8 | N/A | N/A | N/A |
| Nippon India Multi Cap Fund | 1,694,166 | 0.43 | 211.36 | 2,166,707 | 2025-10-30 01:41:28 | -21.81% |
| Tata Value Fund | 1,535,525 | 2.16 | 191.57 | N/A | N/A | N/A |
| Nippon India Small Cap Fund | 1,509,207 | 0.27 | 188.29 | 2,267,244 | 2025-11-02 18:14:38 | -33.43% |
| Nippon India Banking & Financial Services Fund | 1,141,962 | 1.89 | 142.47 | 1,141,962 | 2025-04-22 15:56:52 | 0% |
| Canara Robeco Small Cap Fund | 804,337 | 0.76 | 100.35 | N/A | N/A | N/A |
| Nippon India ELSS Tax Saver Fund | 800,000 | 0.64 | 99.81 | 1,302,681 | 2025-11-03 13:46:06 | -38.59% |
| Nippon India Value Fund | 732,487 | 1 | 91.39 | 788,543 | 2025-10-30 01:41:28 | -7.11% |
| HDFC Value Fund | 440,000 | 0.72 | 54.89 | N/A | N/A | N/A |
| Nippon India Aggressive Hybrid Fund | 439,674 | 1.34 | 54.85 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 57.35 | 60.26 | 34.45 | 42.12 | 38.97 |
| Diluted EPS (Rs.) | 57.11 | 60.22 | 34.44 | 41.96 | 38.97 |
| Cash EPS (Rs.) | 67.08 | 66.34 | 37.77 | 45.01 | 41.81 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 359.36 | 390.79 | 304.60 | 284.97 | 257.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 359.36 | 390.79 | 304.60 | 284.97 | 257.36 |
| Revenue From Operations / Share (Rs.) | 144.64 | 136.49 | 99.77 | 103.91 | 92.16 |
| PBDIT / Share (Rs.) | 86.77 | 81.75 | 50.02 | 55.63 | 51.02 |
| PBIT / Share (Rs.) | 83.21 | 78.43 | 46.87 | 52.73 | 48.20 |
| PBT / Share (Rs.) | 82.21 | 77.55 | 46.12 | 52.00 | 47.56 |
| Net Profit / Share (Rs.) | 63.52 | 63.02 | 34.63 | 42.11 | 38.99 |
| NP After MI And SOA / Share (Rs.) | 57.16 | 60.17 | 34.44 | 42.09 | 38.97 |
| PBDIT Margin (%) | 59.98 | 59.89 | 50.13 | 53.53 | 55.35 |
| PBIT Margin (%) | 57.52 | 57.46 | 46.97 | 50.74 | 52.29 |
| PBT Margin (%) | 56.84 | 56.81 | 46.22 | 50.04 | 51.60 |
| Net Profit Margin (%) | 43.91 | 46.17 | 34.70 | 40.52 | 42.30 |
| NP After MI And SOA Margin (%) | 39.51 | 44.08 | 34.52 | 40.50 | 42.28 |
| Return on Networth / Equity (%) | 15.90 | 17.44 | 11.30 | 14.81 | 15.19 |
| Return on Capital Employeed (%) | 19.99 | 19.69 | 15.17 | 18.10 | 18.05 |
| Return On Assets (%) | 12.92 | 14.33 | 10.47 | 13.39 | 13.53 |
| Asset Turnover Ratio (%) | 0.33 | 0.36 | 0.28 | 0.29 | 0.29 |
| Current Ratio (X) | 15.50 | 17.83 | 14.66 | 12.25 | 12.12 |
| Quick Ratio (X) | 15.50 | 17.83 | 14.66 | 12.25 | 12.12 |
| Dividend Payout Ratio (NP) (%) | 81.84 | 36.48 | 60.96 | 40.34 | 17.96 |
| Dividend Payout Ratio (CP) (%) | 77.04 | 34.57 | 55.86 | 37.74 | 16.74 |
| Earning Retention Ratio (%) | 18.16 | 63.52 | 39.04 | 59.66 | 82.04 |
| Cash Earning Retention Ratio (%) | 22.96 | 65.43 | 44.14 | 62.26 | 83.26 |
| Interest Coverage Ratio (X) | 87.37 | 92.31 | 66.50 | 76.93 | 80.26 |
| Interest Coverage Ratio (Post Tax) (X) | 64.96 | 72.17 | 47.04 | 59.23 | 62.33 |
| Enterprise Value (Cr.) | 13539.42 | 10626.57 | 7783.48 | 12236.34 | 7066.17 |
| EV / Net Operating Revenue (X) | 7.31 | 6.12 | 6.14 | 9.28 | 6.05 |
| EV / EBITDA (X) | 12.19 | 10.21 | 12.26 | 17.33 | 10.92 |
| MarketCap / Net Operating Revenue (X) | 7.28 | 5.97 | 6.43 | 9.57 | 6.32 |
| Retention Ratios (%) | 18.15 | 63.51 | 39.03 | 59.65 | 82.03 |
| Price / BV (X) | 2.93 | 2.36 | 2.10 | 3.50 | 2.27 |
| Price / Net Operating Revenue (X) | 7.28 | 5.97 | 6.43 | 9.57 | 6.32 |
| EarningsYield | 0.05 | 0.07 | 0.05 | 0.04 | 0.06 |
After reviewing the key financial ratios for UTI Asset Management Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 57.35. This value is within the healthy range. It has decreased from 60.26 (Mar 24) to 57.35, marking a decrease of 2.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is 57.11. This value is within the healthy range. It has decreased from 60.22 (Mar 24) to 57.11, marking a decrease of 3.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 67.08. This value is within the healthy range. It has increased from 66.34 (Mar 24) to 67.08, marking an increase of 0.74.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 359.36. It has decreased from 390.79 (Mar 24) to 359.36, marking a decrease of 31.43.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 359.36. It has decreased from 390.79 (Mar 24) to 359.36, marking a decrease of 31.43.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 144.64. It has increased from 136.49 (Mar 24) to 144.64, marking an increase of 8.15.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 86.77. This value is within the healthy range. It has increased from 81.75 (Mar 24) to 86.77, marking an increase of 5.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 83.21. This value is within the healthy range. It has increased from 78.43 (Mar 24) to 83.21, marking an increase of 4.78.
- For PBT / Share (Rs.), as of Mar 25, the value is 82.21. This value is within the healthy range. It has increased from 77.55 (Mar 24) to 82.21, marking an increase of 4.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 63.52. This value is within the healthy range. It has increased from 63.02 (Mar 24) to 63.52, marking an increase of 0.50.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 57.16. This value is within the healthy range. It has decreased from 60.17 (Mar 24) to 57.16, marking a decrease of 3.01.
- For PBDIT Margin (%), as of Mar 25, the value is 59.98. This value is within the healthy range. It has increased from 59.89 (Mar 24) to 59.98, marking an increase of 0.09.
- For PBIT Margin (%), as of Mar 25, the value is 57.52. This value exceeds the healthy maximum of 20. It has increased from 57.46 (Mar 24) to 57.52, marking an increase of 0.06.
- For PBT Margin (%), as of Mar 25, the value is 56.84. This value is within the healthy range. It has increased from 56.81 (Mar 24) to 56.84, marking an increase of 0.03.
- For Net Profit Margin (%), as of Mar 25, the value is 43.91. This value exceeds the healthy maximum of 10. It has decreased from 46.17 (Mar 24) to 43.91, marking a decrease of 2.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 39.51. This value exceeds the healthy maximum of 20. It has decreased from 44.08 (Mar 24) to 39.51, marking a decrease of 4.57.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.90. This value is within the healthy range. It has decreased from 17.44 (Mar 24) to 15.90, marking a decrease of 1.54.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.99. This value is within the healthy range. It has increased from 19.69 (Mar 24) to 19.99, marking an increase of 0.30.
- For Return On Assets (%), as of Mar 25, the value is 12.92. This value is within the healthy range. It has decreased from 14.33 (Mar 24) to 12.92, marking a decrease of 1.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has decreased from 0.36 (Mar 24) to 0.33, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 15.50. This value exceeds the healthy maximum of 3. It has decreased from 17.83 (Mar 24) to 15.50, marking a decrease of 2.33.
- For Quick Ratio (X), as of Mar 25, the value is 15.50. This value exceeds the healthy maximum of 2. It has decreased from 17.83 (Mar 24) to 15.50, marking a decrease of 2.33.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 81.84. This value exceeds the healthy maximum of 50. It has increased from 36.48 (Mar 24) to 81.84, marking an increase of 45.36.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 77.04. This value exceeds the healthy maximum of 50. It has increased from 34.57 (Mar 24) to 77.04, marking an increase of 42.47.
- For Earning Retention Ratio (%), as of Mar 25, the value is 18.16. This value is below the healthy minimum of 40. It has decreased from 63.52 (Mar 24) to 18.16, marking a decrease of 45.36.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 22.96. This value is below the healthy minimum of 40. It has decreased from 65.43 (Mar 24) to 22.96, marking a decrease of 42.47.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 87.37. This value is within the healthy range. It has decreased from 92.31 (Mar 24) to 87.37, marking a decrease of 4.94.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 64.96. This value is within the healthy range. It has decreased from 72.17 (Mar 24) to 64.96, marking a decrease of 7.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 13,539.42. It has increased from 10,626.57 (Mar 24) to 13,539.42, marking an increase of 2,912.85.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.31. This value exceeds the healthy maximum of 3. It has increased from 6.12 (Mar 24) to 7.31, marking an increase of 1.19.
- For EV / EBITDA (X), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 10.21 (Mar 24) to 12.19, marking an increase of 1.98.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.28. This value exceeds the healthy maximum of 3. It has increased from 5.97 (Mar 24) to 7.28, marking an increase of 1.31.
- For Retention Ratios (%), as of Mar 25, the value is 18.15. This value is below the healthy minimum of 30. It has decreased from 63.51 (Mar 24) to 18.15, marking a decrease of 45.36.
- For Price / BV (X), as of Mar 25, the value is 2.93. This value is within the healthy range. It has increased from 2.36 (Mar 24) to 2.93, marking an increase of 0.57.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.28. This value exceeds the healthy maximum of 3. It has increased from 5.97 (Mar 24) to 7.28, marking an increase of 1.31.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.05, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UTI Asset Management Company Ltd:
- Net Profit Margin: 43.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.99% (Industry Average ROCE: 35.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.9% (Industry Average ROE: 26.78%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 64.96
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 15.5
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25 (Industry average Stock P/E: 32.65)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 43.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance - Mutual Funds | UTI Tower, G N Block, Mumbai Maharashtra 400051 | cs@uti.co.in https://www.utimf.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dinesh Kumar Mehrotra | Non Exe.Chairman&Ind.Director |
| Mr. Imtaiyazur Rahman | Managing Director & CEO |
| Mr. Flemming Madsen | Non Exe. & Nominee Director |
| Mr. Srivatsa Desikamani | Non Exe. & Nominee Director |
| Mr. Santosh Kumar | Non Exe. & Nominee Director |
| Mr. Narasimhan Seshadri | Ind. Non-Executive Director |
| Mr. Deepak Kumar Chatterjee | Ind. Non-Executive Director |
| Ms. Jayashree Vaidhyanathan | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of UTI Asset Management Company Ltd?
UTI Asset Management Company Ltd's intrinsic value (as of 13 December 2025) is 1140.23 which is 0.50% lower the current market price of 1,146.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 14,714 Cr. market cap, FY2025-2026 high/low of 1,495/905, reserves of ₹4,257 Cr, and liabilities of 5,435 Cr.
What is the Market Cap of UTI Asset Management Company Ltd?
The Market Cap of UTI Asset Management Company Ltd is 14,714 Cr..
What is the current Stock Price of UTI Asset Management Company Ltd as on 13 December 2025?
The current stock price of UTI Asset Management Company Ltd as on 13 December 2025 is 1,146.
What is the High / Low of UTI Asset Management Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of UTI Asset Management Company Ltd stocks is 1,495/905.
What is the Stock P/E of UTI Asset Management Company Ltd?
The Stock P/E of UTI Asset Management Company Ltd is 25.0.
What is the Book Value of UTI Asset Management Company Ltd?
The Book Value of UTI Asset Management Company Ltd is 342.
What is the Dividend Yield of UTI Asset Management Company Ltd?
The Dividend Yield of UTI Asset Management Company Ltd is 2.27 %.
What is the ROCE of UTI Asset Management Company Ltd?
The ROCE of UTI Asset Management Company Ltd is 21.0 %.
What is the ROE of UTI Asset Management Company Ltd?
The ROE of UTI Asset Management Company Ltd is 16.3 %.
What is the Face Value of UTI Asset Management Company Ltd?
The Face Value of UTI Asset Management Company Ltd is 10.0.